OTCMKTS:QBIO - Q BioMed Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.04 +0.02 (+0.99 %)
(As of 02/19/2019 07:49 AM ET)
Previous Close$2.02
Today's Range$1.95 - $2.15
52-Week Range$0.90 - $3.95
Volume38,566 shs
Average Volume77,822 shs
Market Capitalization$29.47 million
P/E RatioN/A
Dividend YieldN/A
Beta5.22
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical agent for the treatment of pain associated with metastatic bone cancer. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma. Q BioMed Inc. has a partnership with Sphaera Pharma to develop an analog of QBM-001 for pediatric developmental nonverbal disorder; and a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was founded in 2013 and is based in New York, New York.

Receive QBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:QBIO
Previous SymbolNASDAQ:QBIO
CUSIPN/A
Phone212-588-0022

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.03 per share

Profitability

Net Income$-14,540,000.00

Miscellaneous

Employees2
Market Cap$29.47 million
OptionableNot Optionable

Q BioMed (OTCMKTS:QBIO) Frequently Asked Questions

What is Q BioMed's stock symbol?

Q BioMed trades on the OTCMKTS under the ticker symbol "QBIO."

How were Q BioMed's earnings last quarter?

Q BioMed Inc (OTCMKTS:QBIO) announced its quarterly earnings data on Monday, July, 16th. The company reported ($0.14) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.24) by $0.10. View Q BioMed's Earnings History.

What price target have analysts set for QBIO?

1 equities research analysts have issued 12-month target prices for Q BioMed's stock. Their forecasts range from $1.85 to $1.85. On average, they anticipate Q BioMed's share price to reach $1.85 in the next twelve months. This suggests that the stock has a possible downside of 9.3%. View Analyst Price Targets for Q BioMed.

What is the consensus analysts' recommendation for Q BioMed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Q BioMed in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Q BioMed.

Has Q BioMed been receiving favorable news coverage?

News articles about QBIO stock have been trending somewhat positive recently, InfoTrie reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Q BioMed earned a news sentiment score of 1.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the near term.

Who are some of Q BioMed's key competitors?

Who are Q BioMed's key executives?

Q BioMed's management team includes the folowing people:
  • Mr. Denis D. Corin, Chairman, CEO, Pres & CFO (Age 46)
  • Mr. William S. Rosenstadt, Gen. Counsel & Director (Age 51)
  • Mr. David Laskow-Pooley, VP of Product Devel. (Age 65)
  • Mr. Robert Derham, VP of Orphan Products
  • Mr. Ari Jatwes, Bus. Devel. Analyst

How do I buy shares of Q BioMed?

Shares of QBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Q BioMed's stock price today?

One share of QBIO stock can currently be purchased for approximately $2.04.

How big of a company is Q BioMed?

Q BioMed has a market capitalization of $29.47 million. Q BioMed employs 2 workers across the globe.

What is Q BioMed's official website?

The official website for Q BioMed is http://www.qbiomed.com.

How can I contact Q BioMed?

Q BioMed's mailing address is 366 MADISON AVENUE 3RD FLOOR, NEW YORK NY, 10017. The company can be reached via phone at 212-588-0022.


MarketBeat Community Rating for Q BioMed (OTCMKTS QBIO)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Q BioMed and other stocks. Vote "Outperform" if you believe QBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Featured Article: Institutional Investors

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel